LAVAL, Quebec (AP) _ Acasti Pharma Inc. (ACST) on Friday reported a loss of $11.9 million in its fiscal third quarter.
On a per-share basis, the Laval, Quebec-based company said it had a loss of 14 cents.
The results fell short of Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 13 cents per share.
The company's shares closed at 61 cents. A year ago, they were trading at 91 cents.